These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37646994)

  • 1. Scale-Up of Protein Purification: Downstream Processing Issues.
    Milne JJ
    Methods Mol Biol; 2023; 2699():61-75. PubMed ID: 37646994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scale-Up of Protein Purification: Downstream Processing Issues.
    Milne JJ
    Methods Mol Biol; 2017; 1485():71-84. PubMed ID: 27730549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scale-up of protein purification: downstream processing issues.
    Milne JJ
    Methods Mol Biol; 2011; 681():73-85. PubMed ID: 20978961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed-Mode Chromatography and Its Role in Monoclonal Antibody Purification.
    Milne JJ
    Methods Mol Biol; 2023; 2699():15-29. PubMed ID: 37646991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting therapeutic protein purity and yield during chromatographic purification.
    Che Hussian CHA; Leong WY
    Prep Biochem Biotechnol; 2024 Feb; 54(2):150-158. PubMed ID: 37233514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatographic Purification of Viral Vectors for Gene Therapy Applications.
    Kearney AM
    Methods Mol Biol; 2023; 2699():51-60. PubMed ID: 37646993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity chromatography for vaccines manufacturing: Finally ready for prime time?
    Zhao M; Vandersluis M; Stout J; Haupts U; Sanders M; Jacquemart R
    Vaccine; 2019 Aug; 37(36):5491-5503. PubMed ID: 29627235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging biomaterials for downstream manufacturing of therapeutic proteins.
    Li Y; Stern D; Lock LL; Mills J; Ou SH; Morrow M; Xu X; Ghose S; Li ZJ; Cui H
    Acta Biomater; 2019 Sep; 95():73-90. PubMed ID: 30862553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downstream processing of cell culture-derived virus particles.
    Wolf MW; Reichl U
    Expert Rev Vaccines; 2011 Oct; 10(10):1451-75. PubMed ID: 21988309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Novel Affinity Ligand for Lentiviral Vector Purification.
    Moreira AS; Bezemer S; Faria TQ; Detmers F; Hermans P; Sierkstra L; Coroadinha AS; Peixoto C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
    Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
    PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity Chromatography: An Enabling Technology for Large-Scale Bioprocessing.
    Łącki KM; Riske FJ
    Biotechnol J; 2020 Jan; 15(1):e1800397. PubMed ID: 31544994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous downstream processing for high value biological products: A Review.
    Zydney AL
    Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully integrated downstream process to enable next-generation manufacturing.
    Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
    Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust method for chromatogram shape analysis to improve early detection of performance drifts and adverse changes in process parameters during purification column operations.
    Torres AJ
    Biotechnol J; 2024 Jan; 19(1):e2300271. PubMed ID: 38012961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
    Xenopoulos A
    J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous multi-membrane chromatography of large viral particles.
    Matos T; Hoying D; Kristopeit A; Wenger M; Joyce J
    J Chromatogr A; 2023 Aug; 1705():464194. PubMed ID: 37419021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.
    Singh N; Herzer S
    Adv Biochem Eng Biotechnol; 2018; 165():115-178. PubMed ID: 28795201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.